Language： 简体中文 English

Call for Innovative Clinical Drug Research Session

To promote the development of anti-tumor drugs, a special session on Innovative Clinical Drug Research has been established to provide a platform for pharmaceutical companies, research institutions, and researchers to exchange ideas on innovative drug study designs and early clinical research data.
Submissions should be:
1) Early clinical research data from anti-tumor drugs or new technologies;
2) The latest results and recent breakthroughs from published clinical studies.
Any one of the above conditions being met is sufficient for submission. Considering the innovativeness and timeliness of clinical innovation data, this submission process is separate from the regular submission.
The submission information is as follows:
Submission Date: Jun. 29
Submission Deadline: Aug. 15

Unfold

0

DAYS

Countdown

Fold

0

COUNTDOWN